6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Oorspronkelijke tekst

Deze vertaling beoordelen

Je feedback wordt gebruikt om Google Translate te verbeteren

Latest Press Releases

Time	Headline
15m ago	Timberland Bancorp Reports Second Fiscal Quarter Net Income of $7.1 Million
41m ago	CPKC increases dividend by 17.5 percent
41m ago	Waldencast announces conclusion of SEC investigation
41m ago	Nektar to Announce Financial Results for the First Quarter on Thursday, May 7, 2026, After Close of U.S.-Based Financial Markets
42m ago	F5 to Host Analyst and Investor Meeting on May 28, 2026

About

Knight Therapeutics Inc. (TO:GUD) — investor relations, events, news, and company updates on 6ix.

Latest News

Knight to Present at the 2026 Bloom Burton & Co. Healthcare Investor Conference

Knight Therapeutics Inc. ranks on The Globe and Mail's second annual Canada's Top Growing Women-Led Companies and seventh annual Women Lead Here benchmark of executive gender diversity

Knight Amends Normal Course Issuer Bid

Knight Therapeutics Reports Fourth Quarter and Year-End 2025 Results

Knight Therapeutics Announces Approval of Additional Indication for MINJUVI® (tafasitamab) in Brazil

Financials

Revenue

CA$450.09 M

Market Cap

CA$739.7 M

EPS

-0.05

Community Chat

Ask AI